Skip to main content

Table 2 Baseline STI prevalence among cisgender women enrolled in a trial of doxycycline postexposure prophylaxis in Kisumu, Kenya

From: Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention

STI type

n/N(%)

C. trachomatis

63 /448** (14.1%)

N. gonorrhoeae

17 /448** (3.8%)

T. pallidum

2 /449 (0.4%)

STI co-infection

2/448 (0.4%)

Any STI

80 /448** (17.9%)

  1. **One participant enrolled without baseline vaginal swab collection
Back to article page

BMC Women's Health

ISSN: 1472-6874

Contact us